Current Report · Items 2.02, 7.01, 9.01 · 8-K
MPT Operating Partnership, L.P.
Results of Operations and Financial Condition · Regulation FD Disclosure
Item 2.02. Results of Operations and Financial Condition. On August 10, 2026, Medical Properties Trust, Inc. (the “Company” or “MPT”) issued a press release announcing its financial results for the three and six months ended June 30, 2026. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.…
Filed Aug 10, 2026Accepted Aug 10, 2026, 9:25 AM EDTCIK 1524607Accession 0001193125-26-341434
Registered securities in this filing
MEDICAL PROPERTIES TRUST INC · 8-K · Filed 2026-08-10
As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.
Common Stock, par value $0.001 per share, of Medical Properties Trust, Inc.
- Symbol
- MPT
- Exchange
- NYSE
- Classification
- COMMON
Filing context
Context: P08_10_2026To08_10_2026
Dimensions: Not supplied
Accession 000119312526341434 · 1 registered-security cover member
Read the exact SEC filing ↗Disclosure sections
Items 2.02, 7.01, 9.01Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 2.02Item 2.02 - Results of Operations
Item 2.02. Results of Operations and Financial Condition.
On August 10, 2026, Medical Properties Trust, Inc. (the “Company” or “MPT”) issued a press release announcing its financial results for the three and six months ended June 30, 2026. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
The information set forth in this Item 2.02, including the information set forth in Exhibit 99.1 and Exhibit 99.2, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”). In addition, this information shall not be deemed incorporated by reference in any filing of the Company with the Securities and Exchange Commission (the “Commission”), except as expressly set forth by specific reference in any such filing.
Item 7.01Item 7.01 - Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure.
On August 10, 2026, the Company issued a press release announcing that its operating partnership, MPT Operating Partnership, L.P., and its wholly-owned subsidiary, MPT Finance Corporation (together, the “Issuers”), have entered into an exchange and purchase agreement with certain institutional investors providing for a private placement for new money, together with a private exchange for outstanding senior notes, resulting in the issuance of $2.4 billion in aggregate principal amount of new 9.25% senior secured notes due 2032 (the “Notes”). The transaction is expected to close imminently. A copy of the press release is attached as Exhibit 99.3 to this Current Report on Form 8-K and is incorporated herein by reference.
The Company is also furnishing as Exhibit 99.4 to this Current Report on Form 8-K certain information (the “Cleansing Information”) previously shared with certain institutional investors during the course of the discussions leading up to the execution of the exchange and purchase agreement. The Cleansing Information was prepared primarily to facilitate a discussion with the parties to the exchange and purchase agreements, and not with a view toward public disclosure, and should not be relied upon to make an investment decision with respect to the Company. The Cleansing Information should not be regarded as an indication that the Company or any third party considers the Cleansing Information to be material non-public information or a reliable prediction of future events and should not be relied upon as such. The Cleansing Information includes certain values for illustrative purposes only, and such values are not the result of, and do not represent, actual valuations, estimates, forecasts or projections of the Company or any third party and should not be relied upon as such. Neither the Company nor any third party makes any representation to any person regarding the accuracy or completeness of any Cleansing Information or undertakes any obligation to update the Cleansing Information to reflect circumstances existing after the date when the Cleansing Information was prepared or conveyed or to reflect the occurrence of future events, even if any or all of the assumptions underlying the Cleansing Information become or are shown to be incorrect.
The information set forth in this Item 7.01, including the information set forth in Exhibit 99.3 and Exhibit 99.4, shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section or Sections 11 and 12(a)(2) of the Securities Act. In addition, this information shall not be deemed incorporated by reference in any filing of the Company with the Commission, except as expressly set forth by specific reference in any such filing.
No Offer or Sale
MPT is offering and selling the Notes and related guarantees only by, and pursuant to, the terms of an exchange and purchase agreement with certain institutional investors. The Notes have not been registered under the Securities Act, or any other securities laws, and the Notes cannot be offered or sold except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and any other applicable securities laws. This Current Report on Form 8-K shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.
Filed exhibits (2)
EX-99.1 (by filename) d115341dex991.htmEX-99.1
2
d115341dex991.htm
EX-99.1
EX-99.1
Exhibit 99.1
Contact: Charles Lambert
Senior Vice President of Finance & Treasurer
Medical
Properties Trust, Inc.
(205) 397-8897
clambert@mpt.com
MPT REPORTS SECOND
QUARTER RESULTS
Announced Agreement for Private Refinancing Transaction that Significantly Extends Maturities on $2.4 Billion of
Debt
Birmingham, AL - August 10, 2026 - Medical Properties Trust, Inc. (the “Company” or
“MPT”) (NYSE: MPT) today announced financial and operating results for the second quarter ended June 30, 2026, as well as certain events occurring subsequent to quarter end.
Announced a private offering of approximately $2.4 billion of secured notes, the proceeds of which will be
used to repay existing debt, including the 2026 notes as well as approximately 50% of the 2027 notes, expected to close imminently;
Agreed to a sale of certain assets that it expects will result in approximately $172 million of cash
proceeds in the third quarter;
Received approximately $100 million in cash proceeds in connection with the initial public offering of
Infracore SA (“Infracore”), in which MPT holds an equity investment, with an expected additional …
Open exhibit ↗EX-99.2 (by filename) d115341dex992.htmEX-99.2
3
d115341dex992.htm
EX-99.2
EX-99.2
Exhibit 99.2 QUARTERLY SUPPLEMENTAL 2Q 2026 ® AT THE VERY HEART OF
HEALTHCARE.
On the cover and above: MPT has invested more than $350 million to build
a new, state-of-the-art hospital for the Norwood, Massachusetts community following catastrophic flooding that destroyed the former facility in 2020. The 130-bed hospital design is expected to focus on treating acute care conditions. FORWARD-LOOKING
STATEMENTS COMPANY OVERVIEW This press release includes forward-looking statements within the meaning Company Information 3 of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.
Forward-looking statements can generally be identified by the use of forward-looking words such as “may”, “will”, “would”, “could”, “expect”, “intend”, “plan”,
“estimate”, FINANCIAL INFORMATION “target”, “anticipate”, “believe”, “objectives”, “outlook”, “guidance” or other similar words, and include statements regarding our
strategies, Reconciliation of Funds from Operations 6 objectives, prospects, asset sales and the expected proceeds and gains therefrom, refinancings (including the Notes of…
Open exhibit ↗